6.
Luca A, Caruso S, Milazzo M, Marrone G, Mamone G, Crino F
. Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis. Radiology. 2012; 265(1):124-32.
DOI: 10.1148/radiol.12112236.
View
7.
Zocco M, Di Stasio E, De Cristofaro R, Novi M, Ainora M, Ponziani F
. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol. 2009; 51(4):682-9.
DOI: 10.1016/j.jhep.2009.03.013.
View
8.
Faccia M, Ainora M, Ponziani F, Riccardi L, Garcovich M, Gasbarrini A
. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World J Gastroenterol. 2019; 25(31):4437-4451.
PMC: 6710174.
DOI: 10.3748/wjg.v25.i31.4437.
View
9.
Guo D, Fan L, Le Q, Huang C
. Transjugular intrahepatic portosystemic shunt for the prevention of rebleeding in patients with cirrhosis and portal vein thrombosis: Systematic review and meta-analysis. Front Pharmacol. 2022; 13:968988.
PMC: 9424732.
DOI: 10.3389/fphar.2022.968988.
View
10.
Garcia-Pagan J, Saffo S, Mandorfer M, Garcia-Tsao G
. Where does TIPS fit in the management of patients with cirrhosis?. JHEP Rep. 2020; 2(4):100122.
PMC: 7347999.
DOI: 10.1016/j.jhepr.2020.100122.
View
11.
Nicoara-Farcau O, Soy G, Magaz M, Baiges A, Turon F, Garcia-Criado A
. New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis. Semin Thromb Hemost. 2020; 46(6):673-681.
DOI: 10.1055/s-0040-1715473.
View
12.
Xu X, Guo X, De Stefano V, Silva-Junior G, Goyal H, Bai Z
. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis. Hepatol Int. 2019; 13(4):468-481.
DOI: 10.1007/s12072-019-09951-6.
View
13.
Sharma A, Zhu D, Henry Z
. Portal vein thrombosis: When to treat and how?. Vasc Med. 2015; 21(1):61-9.
DOI: 10.1177/1358863X15611224.
View
14.
Ferreira C, Reis D, Cortez-Pinto H, Marinho R, Goncalves A, Palma S
. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis. Dig Dis Sci. 2019; 64(9):2671-2683.
DOI: 10.1007/s10620-019-05572-z.
View
15.
Ferreira C, Marinho R, Cortez-Pinto H, Ferreira P, Dias M, Vasconcelos M
. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study. Liver Int. 2019; 39(8):1459-1467.
DOI: 10.1111/liv.14121.
View
16.
Elhosseiny S, Al Moussawi H, Chalhoub J, Lafferty J, Deeb L
. Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations. Can J Gastroenterol Hepatol. 2019; 2019:4383269.
PMC: 6354142.
DOI: 10.1155/2019/4383269.
View
17.
Maruyama H, Okugawa H, Takahashi M, Yokosuka O
. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol. 2013; 108(4):568-74.
DOI: 10.1038/ajg.2012.452.
View
18.
Lisman T, Hernandez-Gea V, Magnusson M, Roberts L, Stanworth S, Thachil J
. The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease. J Thromb Haemost. 2021; 19(4):1116-1122.
PMC: 8252070.
DOI: 10.1111/jth.15239.
View
19.
Xu S, Guo X, Yang B, Romeiro F, Primignani M, Mendez-Sanchez N
. Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review. Clin Transl Gastroenterol. 2021; 12(10):e00409.
PMC: 8483868.
DOI: 10.14309/ctg.0000000000000409.
View
20.
Nery F, Chevret S, Condat B, de Raucourt E, Boudaoud L, Rautou P
. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology. 2014; 61(2):660-7.
DOI: 10.1002/hep.27546.
View